Supra-Iliac Anterior Quadratus Lumborum Block and Pericapsular Nerve Group (PENG) Block for Analgesia After Total Hip Arthroplasty
Recruiting
N/A
Interventional Study
Supra-Iliac Anterior Quadratus Lumborum Block
Pericapsular Nerve Group Block
Analgesia
Total Hip Arthroplasty
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 50 (estimated)
- Sponsor
- Tanta University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to compare the analgesic efficacy of supra-iliac anterior quadratus lumborum block (SA-QLB) and pericapsular nerve group (PENG) block in patients undergoing total hip arthroplasty (THA).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age from 18 to 75 years.
* Both sexes.
* American Society of Anesthesiologists (ASA) classification I-III.
* Scheduled for primary elective unilateral total hip arthroplasty (THA) under spinal anesthesia.
Exclusion Criteria:
* Known allergies to the drugs used.
* Infection a…
Contacts